Feedback / Questions
isomyosamine (MYMD-1) - MyMD Pharma, Akers Biosci
https://www.businesswire.com/news/home/20231206611024/en/MyMD-Pharmaceuticals-Plans-FDA-Cleared-Phase-2-Clinical-Trial-of-MYMD-1-in-Rheumatoid-Arthritis
Dec 6, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next